Veterinary Medicines

Alfapen-Strep Suspension for Injection for Cattle, Sheep and Pigs

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
Alfapen-Strep Suspension for Injection for Cattle, Sheep and Pigs
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    233.62
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        72
        hour
    • Sheep
      • Meat and offal
        21
        day
    • Pig
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Type II, siliconised clear glass, 50 ml vials closed with nitryl rubber stoppers and sealed with aluminium seals.
  • Type II, siliconised clear glass, 100 ml vials closed with nitryl rubber stoppers and sealed with aluminium seals.
  • Type II, siliconised clear glass, 12 x 100 ml vials closed with nitryl rubber stoppers and sealed with aluminium seals in a cardboard/polystyrene box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfa Med Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfa Med Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10894/003/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 16/02/2025
Download